MedTrace Logo

Neurohormonal Parameters in Hypertrophic Cardiomyopathies

NCT01729702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2014-03-26

No results posted yet for this study

Summary

The primary purpose of this study is to demonstrate that changes in plasma levels of circulating neurohormones (mainly BNP and NT-proBNP), measured at rest and post-exercise correlate with exercise functional limitation (assessed by exercise peak VO2) and exercise ultrasonic parameters (as left ventricular filling, obstruction, and mitral regurgitation)

Conditions

  • 1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy
  • 2- Obstructive Hypertrophic Cardiomyopathy
  • 3- Non Obstructive Hypertrophic Cardiomyopathy

Interventions

OTHER

blood sample collection

Sponsors & Collaborators

  • French Cardiology Society

    lead OTHER

Principal Investigators

  • Albert Hagège, MD-PhD · HEGP - Paris

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01729702 on ClinicalTrials.gov